 SCYNEXIS, Inc. NASDAQ:SCYX Q3 2022 Results Conference Call November 9, 2022 8:30 AM ET Company Participants Debbie Etchison - Communications IR Dr. Marco Taglietti - President CEO Dr. David Angulo - Chief Medical Officer Ivor Macleod - Chief Financial Officer Conference Call Participants Louise Chen - Cantor Michael Higgins - Ladenburg Thalmann Shubhendu Sen Roy - Brookline Capital Markets Operator Good morning, and welcome to the SCYNEXIS Third Quarter 2022 Earnings Conference Call. Operator Instructions Please note, this event is being recorded. 